Progress on application of dipeptidyl peptidase Ⅲ in the treatment of sepsis

Sepsis is still one of the important challenges of medicine in the 21st century. Dipeptide peptidase Ⅲ(DPP3)is a new biomarker associated with sepsis, which mainly degrades angiotensin Ⅱ in human body. It can not only inhibit cardiac systolic function, but also reduce vascular tension, resulting in...

Full description

Bibliographic Details
Main Author: WANG Yingchen, SUN Liqun
Format: Article
Language:zho
Published: Institute of Basic Medical Sciences and Peking Union Medical College Hospital, Chinese Academy of Medical Sciences / Peking Union Medical College. 2023-01-01
Series:Jichu yixue yu linchuang
Subjects:
Online Access:http://journal11.magtechjournal.com/Jwk_jcyxylc/fileup/1001-6325/PDF/1001-6325-2023-43-1-196.pdf
_version_ 1827391063339302912
author WANG Yingchen, SUN Liqun
author_facet WANG Yingchen, SUN Liqun
author_sort WANG Yingchen, SUN Liqun
collection DOAJ
description Sepsis is still one of the important challenges of medicine in the 21st century. Dipeptide peptidase Ⅲ(DPP3)is a new biomarker associated with sepsis, which mainly degrades angiotensin Ⅱ in human body. It can not only inhibit cardiac systolic function, but also reduce vascular tension, resulting in insufficient cardiac output and low blood pressure, resulting in shock and multiple organ dysfunctions in patients with sepsis. Therefore, DPP3 may become a new target for sepsis treatment.
first_indexed 2024-03-08T17:03:15Z
format Article
id doaj.art-a8944ad6abeb4e37a9eaf2637b52ac07
institution Directory Open Access Journal
issn 1001-6325
language zho
last_indexed 2024-03-08T17:03:15Z
publishDate 2023-01-01
publisher Institute of Basic Medical Sciences and Peking Union Medical College Hospital, Chinese Academy of Medical Sciences / Peking Union Medical College.
record_format Article
series Jichu yixue yu linchuang
spelling doaj.art-a8944ad6abeb4e37a9eaf2637b52ac072024-01-04T07:27:26ZzhoInstitute of Basic Medical Sciences and Peking Union Medical College Hospital, Chinese Academy of Medical Sciences / Peking Union Medical College.Jichu yixue yu linchuang1001-63252023-01-0143119619910.16352/j.issn.1001-6325.2023.01.0196Progress on application of dipeptidyl peptidase Ⅲ in the treatment of sepsisWANG Yingchen, SUN Liqun0Intensive Care Unit,the Second Affiliated Hospital of Nanjing Medical University,Nanjing 210000, ChinaSepsis is still one of the important challenges of medicine in the 21st century. Dipeptide peptidase Ⅲ(DPP3)is a new biomarker associated with sepsis, which mainly degrades angiotensin Ⅱ in human body. It can not only inhibit cardiac systolic function, but also reduce vascular tension, resulting in insufficient cardiac output and low blood pressure, resulting in shock and multiple organ dysfunctions in patients with sepsis. Therefore, DPP3 may become a new target for sepsis treatment.http://journal11.magtechjournal.com/Jwk_jcyxylc/fileup/1001-6325/PDF/1001-6325-2023-43-1-196.pdfsepsis|septic shock|dipeptidyl peptidase ⅲ(dpp3)|heart failure
spellingShingle WANG Yingchen, SUN Liqun
Progress on application of dipeptidyl peptidase Ⅲ in the treatment of sepsis
Jichu yixue yu linchuang
sepsis|septic shock|dipeptidyl peptidase ⅲ(dpp3)|heart failure
title Progress on application of dipeptidyl peptidase Ⅲ in the treatment of sepsis
title_full Progress on application of dipeptidyl peptidase Ⅲ in the treatment of sepsis
title_fullStr Progress on application of dipeptidyl peptidase Ⅲ in the treatment of sepsis
title_full_unstemmed Progress on application of dipeptidyl peptidase Ⅲ in the treatment of sepsis
title_short Progress on application of dipeptidyl peptidase Ⅲ in the treatment of sepsis
title_sort progress on application of dipeptidyl peptidase iii in the treatment of sepsis
topic sepsis|septic shock|dipeptidyl peptidase ⅲ(dpp3)|heart failure
url http://journal11.magtechjournal.com/Jwk_jcyxylc/fileup/1001-6325/PDF/1001-6325-2023-43-1-196.pdf
work_keys_str_mv AT wangyingchensunliqun progressonapplicationofdipeptidylpeptidaseiiiinthetreatmentofsepsis